http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111504886-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2015-0065 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2015-1006 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N15-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N15-14 |
| filingDate | 2020-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111504886-B |
| titleOfInvention | Application of a group of molecules in preparation of auxiliary diagnosis reagent or kit for new coronary pneumonia |
| abstract | The invention belongs to the field of biomedicine, and particularly relates to application of a group of molecules in preparation of a new coronarism auxiliary diagnostic reagent or kit. The group of molecules specifically refers to four antibodies, namely anti-human FITC-CD3, FITC-TCR gamma/delta, APC/Cyanine7-CD4 and PerCP/cyanine5.5-CD 8. The component is used for detecting peripheral blood of a patient with new coronary pneumonia by flow cytometry, and experiments prove that a group of CD4+ TCR gamma delta + T cells exist in the peripheral blood of the patient with confirmed diagnosis of the new coronary pneumonia, the detection result can be used for auxiliary diagnosis such as screening, disease condition assessment and the like of a suspected patient with the new coronary pneumonia, and the component has profound clinical significance and important popularization and application prospects. |
| priorityDate | 2020-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.